Preoperative and postoperative prognostic models for progression-free survival
Parameters | Model 1a | Model 2a | Model 3a | Model 4a | Model 5a | Model 6b | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
HR | P Value | HR | P Value | HR | P Value | HR | P Value | HR | P Value | HR | P Value | |
Enhancing tumor volume | 2.9 (1.4–6.0) | .005 | 1.9 (0.9–4.0) | .105 | 2.4 (1.1–5.0) | .023 | 3.1 (1.5–6.7) | .003 | 1.8 (0.8–3.9) | .135 | 1.4 (0.6–3.2) | .423 |
Age | 2.4 (1.2–4.8) | .015 | 3.1 (1.4–6.6) | .004 | 2.4 (1.1–4.9) | .020 | 2.5 (1.2–5.2) | .011 | 3.4 (1.6–7.6) | .002 | 2.4 (1.1–4.9) | .020 |
Ktrans_min | 2.8 (1.4–5.6) | .004 | – | – | 3.3 (1.6–6.7) | .001 | – | – | ||||
Ktrans_p5 | – | 2.9 (1.2–7.2) | .020 | – | – | 4.0 (1.5–10.4) | .004 | – | ||||
ve_kurtosis | – | – | 4.4 (1.7–11.3) | .002 | 5.7 (2.2–15.2) | .000 | 6.0 (2.2–16.3) | .000 | 5.3 (2.0–14.0) | .001 | ||
MGMT | – | – | – | – | – | 3.1 (1.3–7.4) | .012 |